Disconcerting and Counterintuitive Findings from a Trial of Exercise in Cystic Fibrosis: Can Exercise Make Our Patients Worse?

Overview

Journal Am J Respir Crit Care Med

Specialty Critical Care

Date 2021 Dec 2

PMID 34856109

Authors

Melanie Chin

Shawn D Aaron

Affiliations

Soon will be listed here.

References

Shei R, Mackintosh K, Lever J, McNarry M, Krick S . Exercise Physiology Across the Lifespan in Cystic Fibrosis. Front Physiol. 2019; 10:1382. PMC: 6856653. DOI: 10.3389/fphys.2019.01382. View

Hebestreit H, Hulzebos E, Schneiderman J, Karila C, Boas S, Kriemler S . Cardiopulmonary Exercise Testing Provides Additional Prognostic Information in Cystic Fibrosis. Am J Respir Crit Care Med. 2018; 199(8):987-995. DOI: 10.1164/rccm.201806-1110OC. View

Ward N, Stiller K, Holland A . Exercise is commonly used as a substitute for traditional airway clearance techniques by adults with cystic fibrosis in Australia: a survey. J Physiother. 2018; 65(1):43-50. DOI: 10.1016/j.jphys.2018.11.006. View

Nixon P, Orenstein D, Kelsey S, DOERSHUK C . The prognostic value of exercise testing in patients with cystic fibrosis. N Engl J Med. 1992; 327(25):1785-8. DOI: 10.1056/NEJM199212173272504. View

Duff A, Latchford G . Motivational interviewing for adherence problems in cystic fibrosis. Pediatr Pulmonol. 2010; 45(3):211-20. DOI: 10.1002/ppul.21103. View

Button B, Wilson C, Dentice R, Cox N, Middleton A, Tannenbaum E . Physiotherapy for cystic fibrosis in Australia and New Zealand: A clinical practice guideline. Respirology. 2016; 21(4):656-67. PMC: 4840479. DOI: 10.1111/resp.12764. View

Flume P, Robinson K, OSullivan B, Finder J, Vender R, Willey-Courand D . Cystic fibrosis pulmonary guidelines: airway clearance therapies. Respir Care. 2009; 54(4):522-37. View

Radtke T, Nevitt S, Hebestreit H, Kriemler S . Physical exercise training for cystic fibrosis. Cochrane Database Syst Rev. 2017; 11:CD002768. PMC: 6485991. DOI: 10.1002/14651858.CD002768.pub4. View

Sawicki G, Sellers D, Robinson W . High treatment burden in adults with cystic fibrosis: challenges to disease self-management. J Cyst Fibros. 2008; 8(2):91-6. PMC: 2680350. DOI: 10.1016/j.jcf.2008.09.007. View

10.

Hebestreit H, Kriemler S, Schindler C, Stein L, Karila C, Urquhart D . Effects of a Partially Supervised Conditioning Program in Cystic Fibrosis: An International Multicenter, Randomized Controlled Trial (ACTIVATE-CF). Am J Respir Crit Care Med. 2021; 205(3):330-339. PMC: 8887001. DOI: 10.1164/rccm.202106-1419OC. View

11.

Ramsey B, Pepe M, Quan J, Otto K, Montgomery A, Borowitz D . Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N Engl J Med. 1999; 340(1):23-30. DOI: 10.1056/NEJM199901073400104. View

12.

Stanojevic S, Ratjen F . Physiologic endpoints for clinical studies for cystic fibrosis. J Cyst Fibros. 2016; 15(4):416-23. DOI: 10.1016/j.jcf.2016.05.014. View

13.

Hatziagorou E, Kampouras A, Avramidou V, Toulia I, Chrysochoou E, Galogavrou M . Toward the Establishment of New Clinical Endpoints for Cystic Fibrosis: The Role of Lung Clearance Index and Cardiopulmonary Exercise Testing. Front Pediatr. 2021; 9:635719. PMC: 7946844. DOI: 10.3389/fped.2021.635719. View

14.

Middleton P, Mall M, Drevinek P, Lands L, McKone E, Polineni D . Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele. N Engl J Med. 2019; 381(19):1809-1819. PMC: 7282384. DOI: 10.1056/NEJMoa1908639. View